Vemurafenib resistance signature by proteome analysis offers new strategies and rational therapeutic concepts. (2015)

First Author: Paulitschke V
Attributed to:  A new approach to Science at the Life Sciences Interface funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/1535-7163.mct-14-0701

PubMed Identifier: 25612618

Publication URI: http://europepmc.org/abstract/MED/25612618

Type: Journal Article/Review

Volume: 14

Parent Publication: Molecular cancer therapeutics

Issue: 3

ISSN: 1535-7163